Cerity Partners LLC Has $510,000 Holdings in Chemed Co. (NYSE:CHE)

Cerity Partners LLC raised its position in shares of Chemed Co. (NYSE:CHE) by 30.8% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 849 shares of the company’s stock after acquiring an additional 200 shares during the period. Cerity Partners LLC’s holdings in Chemed were worth $510,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Cetera Advisors LLC acquired a new position in Chemed in the 1st quarter valued at $267,000. GAMMA Investing LLC grew its stake in shares of Chemed by 34.4% in the second quarter. GAMMA Investing LLC now owns 86 shares of the company’s stock valued at $47,000 after acquiring an additional 22 shares in the last quarter. CWM LLC increased its position in Chemed by 18.5% during the second quarter. CWM LLC now owns 397 shares of the company’s stock worth $215,000 after acquiring an additional 62 shares during the period. OLD National Bancorp IN acquired a new stake in Chemed in the 2nd quarter worth about $313,000. Finally, SG Americas Securities LLC boosted its holdings in Chemed by 422.9% in the 2nd quarter. SG Americas Securities LLC now owns 7,551 shares of the company’s stock valued at $4,097,000 after purchasing an additional 6,107 shares during the period. Institutional investors and hedge funds own 95.85% of the company’s stock.

Chemed Stock Down 0.6 %

Shares of Chemed stock opened at $552.62 on Friday. Chemed Co. has a 12-month low of $523.33 and a 12-month high of $654.62. The company has a market capitalization of $8.32 billion, a price-to-earnings ratio of 27.92, a PEG ratio of 2.42 and a beta of 0.46. The firm’s 50-day moving average price is $574.95 and its two-hundred day moving average price is $564.98.

Chemed (NYSE:CHE) last posted its quarterly earnings results on Tuesday, October 29th. The company reported $5.64 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.76 by ($0.12). Chemed had a return on equity of 27.86% and a net margin of 12.69%. The firm had revenue of $606.18 million for the quarter, compared to analyst estimates of $612.22 million. During the same quarter in the prior year, the business posted $5.32 EPS. The business’s revenue was up 7.4% on a year-over-year basis. On average, sell-side analysts expect that Chemed Co. will post 21.43 earnings per share for the current year.

Chemed Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, December 6th. Stockholders of record on Monday, November 18th were issued a dividend of $0.50 per share. The ex-dividend date of this dividend was Monday, November 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.36%. Chemed’s dividend payout ratio (DPR) is currently 10.11%.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on CHE. Royal Bank of Canada dropped their price target on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a research report on Tuesday, November 5th. StockNews.com upgraded Chemed from a “hold” rating to a “buy” rating in a research note on Saturday, November 30th.

Insider Buying and Selling

In related news, Director George J. Walsh III sold 400 shares of the stock in a transaction that occurred on Thursday, September 26th. The shares were sold at an average price of $597.47, for a total value of $238,988.00. Following the completion of the transaction, the director now owns 3,046 shares of the company’s stock, valued at $1,819,893.62. This represents a 11.61 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Spencer S. Lee sold 732 shares of the business’s stock in a transaction on Wednesday, November 27th. The stock was sold at an average price of $575.62, for a total transaction of $421,353.84. Following the sale, the executive vice president now directly owns 18,287 shares in the company, valued at approximately $10,526,362.94. The trade was a 3.85 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 6,845 shares of company stock worth $3,978,798 in the last ninety days. 3.32% of the stock is owned by insiders.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.